Shanghai Fosun Pharmaceutical (HKG:2196, SHA:600196), along with its controlling shareholder and subsidiaries, agreed to extend the shareholder loans worth 80.8 million yuan provided to Fuyun Health for another year, according to a Shanghai bourse filing over the weekend.
The Chinese pharmaceutical company's Hong Kong shares jumped 7%, while Shanghai shares rose 1% during Monday's midday trade.
The loans' extended maturity date will be Sept. 4, 2027, and the annual interest rate during the extension period will remain at 3.2%.